AJJ Medtech Holdings Limited

AJJ Medtech Holdings Limited

SSGX:584
0.00
SGD
+0.00
(+33.33%)
0.00EPS
8.66MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
0.02
-0.03
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.04
-0.03
-0.01
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.07
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
- -
- -
- -
- -
- -
Tangible Book Value per Share
0.07
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
668
668
668
668
668
668
668
770
934
934
934
1,367
1,529
1,619
Sales/Revenue/Turnover
9
4
1
1
1
1
- -
1
- -
1
2
2
3
3
Operating Margin (%)
-205.72
-561.53
-42.34
10.1
-36.02
-52.17
-527.22
-402.2
-1,228.53
-660.07
-155.29
-167.63
-90.04
-123.95
Depreciation Expense
1
2
2
2
- -
- -
1
1
1
1
- -
- -
- -
- -
Net Income, GAAP
15
-19
-9
-6
- -
-1
-1
-3
-2
-4
-3
-4
-3
-3
Effective Tax Rate (%)
- -
- -
- -
264.47
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
167.57
-442.67
-1,229.61
-643.33
-43.55
-70.33
-530.56
-405.71
-531.66
-711.58
-156.47
-166.38
-91.82
-127.43
Working Capital
22
5
1
-2
-1
-2
-2
6
4
1
-1
-2
-3
-4
LT Debt
2
- -
- -
- -
- -
- -
7
- -
1
1
1
1
1
1
Total Equity
46
20
14
7
7
7
6
7
5
1
-1
-1
-3
-4
Return on Invested Capital (%)
- -
- -
- -
-1.44
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-55.89
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
39.54
-57.53
-54.39
-59.71
-5.78
-7.65
-15.91
-43.86
-26.98
-127.8
- -
- -
- -
- -

Capital Structure

SGD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,712
1,712
1,732
Market Capitalization
17
10
9

Working Capital

SGD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
- -
1
Inventories
1
1
1
Total Current Liabilities
5
5
6
Payables & Accruals
- -
- -
- -
ST Debt
2
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-25%
-41.13%
85.44%
Free Cash Flow
1,182.02%
58.23%
-25.12%
Net Income, GAAP
27.56%
19.93%
-24.17%
Sales/Revenue/Turnover
49.15%
57.15%
37.41%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1
1
- -
1
2
2025
1
1
- -
1
3
2026
- -
1
- -
- -
- -

Quarterly Earnings Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Wei Jie Tan
Sector
Consumer services
Industry
Other consumer services
Address
Singapore Singapore
IPO Date
Dec 3, 1994
Website
ohldg.com
Business
AJJ Medtech Holdings Limited is an investment holding company that operates as an integrated medical technology provider and healthcare solutions specialist in the Asia-Pacific region. The company operates through several core business segments, encompassing MedTech Innovations, Medical Device Distribution, Digital Health Solutions, and Healthcare Services. Its primary products and services include the procurement, regulatory management, and distribution of advanced medical devices, surgical instruments, and orthopaedic implants; in-vitro diagnostic equipment, rapid test kits, and point-of-care testing systems; hospital-grade medical consumables, wound care products, and personal protective equipment; artificial intelligence-driven diagnostic software, smart imaging solutions, and clinical workflow automation platforms; telehealth infrastructure, remote patient monitoring tools, and digital clinic management systems; and specialized healthcare services comprising aesthetic medicine, wellness therapies, dermatology, anaesthesiology, and pain management consultancy. AJJ Medtech Holdings Limited serves a diverse client base that includes government and private hospital networks, ambulatory surgical centers, outpatient medical clinics, diagnostic laboratories, healthcare professionals, and individual patients across Singapore, Malaysia, and the broader Southeast Asian market. Founded in 2004 and headquartered in Singapore, the company operates via several operating subsidiaries across medical device distribution and healthcare delivery. In major recent corporate developments, the company executed a strategic restructuring and corporate name change from Livingstone Health Holdings Limited to AJJ Medtech Holdings Limited in February 2024 to signify its expanded focus on medical technology, artificial intelligence healthcare integration, and biomedical supply chain services. Within the last two years, the company has broadened its product portfolio through strategic alliances and distribution partnerships with international medtech innovators and artificial intelligence developers, streamlined its legacy healthcare clinic operations, and completed private share placements to strengthen its balance sheet and fund strategic acquisitions in the regional digital health and medical device sectors.